Submit Manuscript  

Article Details


Erratum to Design, Synthesis and Biological Evaluation of a Phenyl Butyric Acid Derivative, N-(4-chlorophenyl)-4- phenylbutanamide: A HDAC6 Inhibitor with Anti-proliferative Activity on Cervix Cancer and Leukemia Cells

[ Vol. 18 , Issue. 8 ]

Author(s):

  Pages 1218 - 1218 ( 1 )

Abstract:


Due to an oversight one of the author’s name was published wrong in the article entitled “Design, Synthesis and Biological Evaluation of a Phenyl Butyric Acid Derivative, N-(4-chlorophenyl)-4- phenylbutanamide: A HDAC6 Inhibitor with Anti-proliferative Activity on Cervix Cancer and Leukemia Cells” in “Anti-Cancer Agents in Medicinal Chemistry, 2017, Vol. 17, No. 10. pp. 1441.” The correct names of all authors are given below: Rodríguez-Fonseca RA, Sixto-López Y, Fragoso-Vázquez MJ, Flores-Mejía R, Cabrera-Pérez LC, Vázquez-Moctezuma I, Rosales-Hernández MC, Bello M, Martínez-Archundia M, Trujillo-Ferrara JG, Becerra-Martínez E, Correa-Basurto J.

Erratum, to, Design,, Synthesis, and, Biological, Evaluation, of, a, Phenyl, Butyric, Acid, Derivative,, N-(4-chlorophenyl)-4-, phenylbutanamide:, A, HDAC6, Inhibitor, with, Anti-proliferative, Activity, on, Cervix, Cancer, and, Leukemia, Cells

Read Full-Text article